Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27312090)

Published in Sci Rep on June 17, 2016

Authors

Yedi Zhou1, Shigeo Yoshida1, Yuki Kubo1, Yoshiyuki Kobayashi1, Takahito Nakama1, Muneo Yamaguchi1, Keijiro Ishikawa1, Shintaro Nakao1, Yasuhiro Ikeda1, Tatsuro Ishibashi1, Koh-Hei Sonoda1

Author Affiliations

1: Department of Ophthalmology, Kyushu University Graduate School of Medical Sciences, Fukuoka, 812-8582, Japan.

Articles cited by this

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 19.80

The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 19.38

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med (1993) 8.03

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature (2008) 7.10

IL-23 promotes tumour incidence and growth. Nature (2006) 6.30

IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity (1996) 6.16

Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature (1996) 5.45

Cloning and expression of murine IL-12. J Immunol (1992) 4.92

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci U S A (1991) 4.48

Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med (1993) 4.04

IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol (1998) 3.56

Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst (1995) 3.53

Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc (2009) 3.31

IL-12 family cytokines: immunological playmakers. Nat Immunol (2012) 3.12

Interleukin-12: biological properties and clinical application. Clin Cancer Res (2007) 3.00

Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol (2012) 2.94

Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol (1994) 2.68

Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect Immun (1998) 2.60

M1 and M2 Macrophages: Oracles of Health and Disease. Crit Rev Immunol (2012) 2.49

Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood (1996) 2.09

The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol (1998) 1.72

The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets (2009) 1.64

Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1999) 1.62

IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol (1996) 1.54

IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol (2000) 1.46

High-resolution transcriptome of human macrophages. PLoS One (2012) 1.42

Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion. Jpn J Ophthalmol (2011) 1.41

Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell (2005) 1.35

Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol (2013) 1.34

Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12. J Leukoc Biol (1998) 1.32

Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12. Cancer Res (2000) 1.30

Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS One (2008) 1.17

Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile. J Leukoc Biol (2002) 1.17

IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J Immunol (2001) 1.16

Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood (1999) 1.15

Sustained IL-12 signaling is required for Th1 development. J Immunol (2004) 1.15

IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J Immunol (2001) 1.10

Regulation of VEGF expression in human retinal cells by cytokines: implications for the role of inflammation in age-related macular degeneration. J Cell Physiol (2012) 1.10

New insights into IL-12-mediated tumor suppression. Cell Death Differ (2014) 1.09

Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12. Clin Cancer Res (2004) 1.08

Mechanism of inhibition of LPS-induced IL-12p40 production by IL-10 and TGF-beta in ANA-1 cells. J Leukoc Biol (1998) 1.03

Expression of murine IL-12 is regulated by translational control of the p35 subunit. J Immunol (1999) 1.00

Paradoxic effects of metformin on endothelial cells and angiogenesis. Carcinogenesis (2014) 1.00

ROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration. Cell Rep (2015) 0.97

Periostin promotes the generation of fibrous membranes in proliferative vitreoretinopathy. FASEB J (2013) 0.97

Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes. Mol Vis (2012) 0.97

Gene expression profile of hyperoxic and hypoxic retinas in a mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2010) 0.95

Interleukin-18 regulates pathological intraocular neovascularization. J Leukoc Biol (2007) 0.95

TEM7 (PLXDC1) in neovascular endothelial cells of fibrovascular membranes from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci (2008) 0.90

IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients. Graefes Arch Clin Exp Ophthalmol (2012) 0.87

M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci (2015) 0.87

Bone marrow-derived monocyte lineage cells recruited by MIP-1β promote physiological revascularization in mouse model of oxygen-induced retinopathy. Lab Invest (2011) 0.86

Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation. Br J Ophthalmol (2014) 0.84

Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin. Br J Ophthalmol (2014) 0.83

Intraocular neovascularization. Histol Histopathol (1999) 0.78

Producer cells of interleukin 12. Parasitol Today (1993) 0.78

Involvement of periostin in regression of hyaloidvascular system during ocular development. Invest Ophthalmol Vis Sci (2012) 0.78

Bacterial expression, purification and angiogenesis-promoting activity of human thymosin β4. Protein Expr Purif (2013) 0.77

Articles by these authors

Periostin in vitreoretinal diseases. Cell Mol Life Sci (2017) 0.75